Rar | Iv

is the dominant receptor (87%) in human epidermis. It explains how retinoids (like retinol) work in the skin, which is crucial for dermatology research.

A research paper on "RareLink," a framework for rare disease data interoperability. IV rar

One search result mentions that in the MIMIC-IV database (a large critical care database), a parameter identified as RAR was used to predict one-year mortality with a Hazard Ratio (HR) of 1.29. is the dominant receptor (87%) in human epidermis